# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA707653 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 2 ug/mL | Mus musculus | 15 | cell-based format | Scientific Literature | ||
2. | ALA707655 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, FL-1at 4 ug/mL | Mus musculus | 2 | cell-based format | Scientific Literature | ||
3. | ALA880751 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 2 ug/mL. | Mus musculus | 15 | cell-based format | Scientific Literature | ||
4. | ALA707658 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by shrinkage (FSC) at 4 ug/mL. | Mus musculus | 2 | cell-based format | Scientific Literature | ||
5. | ALA707660 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 2 ug/mL. | Mus musculus | 15 | cell-based format | Scientific Literature | ||
6. | ALA712665 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, by Granulation (SSC) at 4 ug/mL. | Mus musculus | 2 | cell-based format | Scientific Literature | ||
7. | ALA712666 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 2 ug/mL. | Mus musculus | 15 | cell-based format | Scientific Literature | ||
8. | ALA712668 | F | Ability to reverse the multidrug resistance (MDR) of mouse Lymphoma cells, fluorescence activity ratio at 4 ug/mL. | Mus musculus | 2 | cell-based format | Scientific Literature | ||
9. | ALA1816691 | F | Antiproliferative activity against human HeLa cells assessed as growth inhibition at 10 ug/mL after 72 hrs by MTT assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
10. | ALA1816692 | F | Antiproliferative activity against human Ishikawa cells assessed as growth inhibition at 10 ug/mL after 72 hrs by MTT assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
11. | ALA1816693 | F | Antiproliferative activity against human MCF7 cells assessed as growth inhibition at 10 ug/mL after 72 hrs by MTT assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
12. | ALA1816694 | F | Antiproliferative activity against human HeLa cells assessed as growth inhibition at 30 ug/mL after 72 hrs by MTT assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
13. | ALA1816797 | F | Antiproliferative activity against human Ishikawa cells assessed as growth inhibition at 30 ug/mL after 72 hrs by MTT assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
14. | ALA1816798 | F | Antiproliferative activity against human MCF7 cells assessed as growth inhibition at 30 ug/mL after 72 hrs by MTT assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
15. | ALA1816799 | B | Inhibition of MDR1-mediated rhodamine 123 uptake expressed in mouse L5178Y cells transfected with pHa MDR1/A assessed as fluorescence activity ratio at 4 ug/mL by flow cytometry relative to untreated control | 13 | cell-based format | Scientific Literature | |||
16. | ALA1816800 | B | Inhibition of MDR1-mediated rhodamine 123 uptake expressed in mouse L5178Y cells transfected with pHa MDR1/A assessed as fluorescence activity ratio at 40 ug/mL by flow cytometry relative to untreated control | 13 | cell-based format | Scientific Literature |